Skopos Labs, Inc. Ptc Therapeutics, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 4 shares of PTCT stock, worth $195. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 18
77.78%
Holding current value
$195
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
284Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$420 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$380 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$365 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$265 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$265 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.49B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...